LMR Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-114,937
Closed -$4.84M 1068
2023
Q2
$4.84M Buy
+114,937
New +$4.65M 0.05% 255
2021
Q2
Sell
-30,000
Closed -$2.28M 1407
2021
Q1
$2.28M Buy
+30,000
New +$2.26M 0.06% 305
2020
Q4
Sell
-15,388
Closed -$818K 660
2020
Q3
$818K Sell
15,388
-2,716
-15% -$162K 0.02% 231
2020
Q2
$1.05M Buy
+18,104
New +$973K 0.03% 351

Other funds holding SYNH

LMR Partners's SYNH Position: Q3 2023 in Review

LMR Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 114,937 shares — an estimated $4.84M sold.

LMR Partners first reported a position in SYNH in Q2 2020 and held it in 4 quarters. The position peaked at $4.84M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • LMR Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • LMR Partners sold 114,937 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $4.84M.
  • LMR Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2020 and held it in 4 quarters.
  • LMR Partners's Syneos Health, Inc. Class A Common Stock position peaked at $4.84M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on LMR Partners's 13F filing for Q3 2023, filed 14 Nov 2023.